Psychiatry & Neurology, Addiction Medicine · Houston, TX
NPI
1316105232
Since 2008
Specialty
Psychiatry & Neurology, Addiction Medicine
Code 2084A0401X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
4800 W 34th St Ste B3
Houston, TX, 77092
Phone (713) 956-7712
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
6,311 prescriptions
Company payments, 2025
$4,638
From 19 companies
Medicare prescription drug claims, 2024
In 2024, the drug Gloria A Maguadog prescribed most often to Medicare patients was Quetiapine Fumarate, with 535 prescriptions and refills. In total Gloria A Maguadog wrote 6,311 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Quetiapine Fumarate Generic | 535 | 536 | 99 | $7,980 |
| Mirtazapine Generic | 305 | 305 | 82 | $3,351 |
| Trazodone Hcl Generic | 292 | 298 | 77 | $2,119 |
| Buspirone Hcl Generic | 291 | 291 | 74 | $3,878 |
| Benztropine Mesylate Generic | 274 | 289 | 70 | $3,593 |
| Clonazepam Generic | 241 | 241 | 56 | $1,877 |
| Sertraline Hcl Generic | 214 | 218 | 59 | $1,282 |
| Risperidone Generic | 212 | 225 | 52 | $2,870 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 211 | 212 | 55 | $17K |
| Divalproex Sodium Er Divalproex Sodium | 182 | 205 | 36 | $9,077 |
| Aripiprazole Generic | 178 | 183 | 42 | $13K |
| Gabapentin Generic | 174 | 180 | 45 | $2,750 |
| Duloxetine Hcl Generic | 154 | 156 | 32 | $1,757 |
| Hydroxyzine Hcl Generic | 139 | 140 | 40 | $3,467 |
| Escitalopram Oxalate Generic | 117 | 121 | 30 | $608 |
Brand drugs: - claims; generic drugs: 5,579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gloria A Maguadog $4,638 ($4,638 in general payments such as food, travel and fees) from 19 companies. The largest payer was Neurocrine BioSciences, Inc. with $883.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 33 | $883 |
| Teva Pharmaceuticals USA, Inc. TEVA | 35 | $745 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 33 | $620 |
| E.R. Squibb & Sons, L.L.C. BMY | 27 | $480 |
| Alkermes, Inc. ALKS | 23 | $464 |
| Vanda Pharmaceuticals Inc. VNDA | 16 | $340 |
| Janssen Pharmaceuticals, Inc JNJ | 18 | $299 |
| Lundbeck LLC | 8 | $174 |
| Supernus Pharmaceuticals, Inc. SUPN | 7 | $133 |
| Tris Pharma Inc | 4 | $92.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.